United States · Series A startup

Who invested in Vicept Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$16Mraised across 1 round since 2010, from 1 source

Latest round
Series A, $16MJun 2010
Investors
5
See who backed them

The rounds

  1. Jun 2010
    Series A$16M

    Reported by vicepttx.comSEC filing: $16M sold, first sale Aug 2009

The exit

ExitBuyerPriceWhen
AcquiredAllergan$275MJul 2011

From historical deal records. Wrong? Tell us.

Everyone who backed them

F-Prime CapitalVC firm1round
Vivo VenturesVC firm1round
Fidelity BiosciencesInvestment firm1round
UCLA VC FundVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Vicept Therapeutics

Who invested in Vicept Therapeutics?

Vicept Therapeutics's investors include F-Prime Capital, Sofinnova Investments, Vivo Ventures, Fidelity Biosciences and UCLA VC Fund.

How much has Vicept Therapeutics raised?

Vicept Therapeutics has raised $16M across 1 round since 2010.

When did Vicept Therapeutics last raise?

Vicept Therapeutics's most recent round was a Series A of $16M in Jun 2010.

What was Vicept Therapeutics's biggest round?

Its most recent round, $16M in Jun 2010, is also its largest on record.

Who backed Vicept Therapeutics first?

Vicept Therapeutics's first round on record, in Jun 2010, was backed by F-Prime Capital, Sofinnova Investments and Vivo Ventures and 2 others.

What stage is Vicept Therapeutics at?

Vicept Therapeutics's latest named round is a Series A, in Jun 2010.

Where is Vicept Therapeutics based?

Vicept Therapeutics is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.